EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Evaluation of the effect of Er,Cr:YSGG laser application on peri‐implant crevicular fluid receptor activator of nuclear factor‐kappa B ligand and osteoprotegerin levels in the non‐surgical treatment of peri‐implantitis: A randomized clinical trial

Nazli Zeynep Alpaslan iD, Dicle Altindal iD, Damla Akbal iD, Ahmet Cemil Talmac iD, Serap Keskin Tunc iD, Abdullah Seckin Ertugrul iD

Journal of Periodontology · 2024

DOI: 10.1002/jper.23-0540 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontology, 2024. Verfasst von Nazli Zeynep Alpaslan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Department of Periodontology, Van Yuzuncu Yil University, Van, Turkey. Hauptthemen laut MEDLINE: Osteoprotegerin, Peri-Implantitis, RANK Ligand, Lasers, Solid-State. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to investigate the effect of erbium, chromium doped:yttrium,scandium,gallium,garnet (Er,Cr:YSGG) laser application combined with non‐surgical mechanical debridement (MD) on clinical parameters and peri‐implant crevicular fluid receptor activator of nuclear factor‐kappa B ligand (RANKL) and osteoprotegerin (OPG) levels in the treatment of peri‐implantitis.

Methods

A total of 49 patients who underwent non‐surgical treatment of peri‐implantitis were randomly divided into two groups. The control group ( n = 26) received MD alone, while the laser group ( n = 23) received MD+Er,Cr:YSGG. The clinical parameters (bleeding on probing [BoP], gingival index [GI], plaque index [PI], probing depth [PD]), marginal bone loss (MBL), and biochemical parameters (RANKL and OPG) were measured at baseline (T0) and 6 months after treatment (T1).

Results

There was a statistically significant decrease in all the clinical parameters in both groups at T1 compared to T0 ( p < 0.05). The BoP, PD, MBL, and RANKL reductions were significantly higher in the laser group than in the control group ( p = 0.046, p = 0.014, p = 0.047, p = 0.045, respectively). The OPG levels significantly increased at T1 in the laser group ( p = 0.01). The OPG/RANKL ratio increased significantly in both groups at T1, which favored the laser group ( p = 0.034).

Conclusions

Although both treatment methods were influential in treating peri‐implantitis, the laser group (MD+Er,Cr:YSGG) yielded more favorable results by reducing clinical inflammation and improving biochemical parameters. Based on these findings, Er,Cr:YSGG laser may be a beneficial adjunctive treatment in this patient group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoprotegerinPeri-ImplantitisRANK LigandLasers, Solid-StateGingival Crevicular FluidHumansFemaleMaleMiddle AgedPeriodontal IndexAgedAdultDental Plaque IndexTreatment OutcomeDebridementDental ImplantsAlveolar Bone Loss

Stichwörter der Autor:innen

RANKLbiomarkersclinical triallasersosteoprotegerinperi‐implantitis

Substanzen

OsteoprotegerinRANK LigandTNFSF11 protein, humanDental ImplantsTNFRSF11B protein, human

Autor:innen und Institutionen

  • Faculty of Dentistry, Department of Periodontology, Van Yuzuncu Yil University, Van, Turkey.
  • Ave Dent Private Clinic, Istanbul, Turkey.
  • Hamidiye Faculty of Dental Medicine, Department of Oral and Maxillofacial Surgery, University of Health Sciences, Istanbul, Turkey.
  • Faculty of Dentistry, Department of Periodontology, Izmir Katip Celebi University, Izmir, Turkey.

ORCID-Profile: Nazli Zeynep Alpaslan, Dicle Altindal, Damla Akbal, Ahmet Cemil Talmac, Serap Keskin Tunc, Abdullah Seckin Ertugrul

Zitieren

APA

Alpaslan, N. Z., Altindal, D., Akbal, D., Talmac, A. C., Keskin Tunc, S., & Ertugrul, A. S. (2024). Evaluation of the effect of Er,Cr:YSGG laser application on peri‐implant crevicular fluid receptor activator of nuclear factor‐kappa B ligand and osteoprotegerin levels in the non‐surgical treatment of peri‐implantitis: A randomized clinical trial. Journal of Periodontology. https://doi.org/10.1002/jper.23-0540

Vancouver

Alpaslan NZ, Altindal D, Akbal D, Talmac AC, Keskin Tunc S, Ertugrul AS. Evaluation of the effect of Er,Cr:YSGG laser application on peri‐implant crevicular fluid receptor activator of nuclear factor‐kappa B ligand and osteoprotegerin levels in the non‐surgical treatment of peri‐implantitis: A randomized clinical trial. Journal of Periodontology. 2024. doi:10.1002/jper.23-0540

BibTeX
@article{Alpaslan2024,
  author = {Alpaslan, Nazli Zeynep and Altindal, Dicle and Akbal, Damla and Talmac, Ahmet Cemil and Keskin Tunc, Serap and Ertugrul, Abdullah Seckin},
  title = {Evaluation of the effect of Er,Cr:YSGG laser application on peri‐implant crevicular fluid receptor activator of nuclear factor‐kappa B ligand and osteoprotegerin levels in the non‐surgical treatment of peri‐implantitis: A randomized clinical trial},
  journal = {Journal of Periodontology},
  year = {2024},
  doi = {10.1002/jper.23-0540}
}
Kostenlos starten →